United States · FDA National Drug Code directory
Olanzapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-067_2b861570-6b18-4b2b-89aa-29ebde7770f5
- Product NDC
- 33342-067
- Form
- TABLET, FILM COATED
- Composition / generic term
- Olanzapine
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140822
- Source listing expiry
- 20271231
Source-listed ingredients
- OLANZAPINE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (33342-067-07) · 33342-067-07
- 100 TABLET, FILM COATED in 1 BOTTLE (33342-067-11) · 33342-067-11
- 10 BLISTER PACK in 1 CARTON (33342-067-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 33342-067-12
- 1000 TABLET, FILM COATED in 1 BOTTLE (33342-067-44) · 33342-067-44
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →